1、Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549 FORM 10-K (Mark One)X XANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended April 30,2024OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIE
2、S EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-41422 HEART TEST LABORATORIES,INC.(Exact name of Registrant as specified in its Charter)TEXAS26-1344466(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)550 Reserve Street
3、,Suite 360Southlake,Texas 76092(Address of principal executive offices)(Zip Code)Registrants telephone number,including area code:(682)-237-7781 Securities registered pursuant to Section 12(b)of the Act:Title of each class TradingSymbol(s)Name of each exchange on which registeredCommon StockWarrants
4、 HSCSHSCSW The Nasdaq Stock Market LLCThe Nasdaq Stock Market LLC Securities registered pursuant to Section 12(g)of the Act:NoneIndicate by check mark if the Registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No XIndicate by check mark if the Registrant is no
5、t required to file reports pursuant to Section 13 or 15(d)of the Act.Yes No XIndicate by check mark whether the Registrant:(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the Reg
6、istrant was required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes X No Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T(232.405 o